Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Theranostic Advances in Breast Cancer in Nuclear Medicine Publisher Pubmed



Vahidfar N1 ; Aghanejad A2 ; Ahmadzadehfar H3 ; Farzanehfar S1 ; Eppard E4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, 1419733141, Iran
  2. 2. Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, 51368, Iran
  3. 3. Department of Nuclear Medicine, Klinikum Westfalen, Dortmund, 44149, Germany
  4. 4. Positronpharma SA. Rancagua 878, Santiago, 7500621, Chile
  5. 5. Department of Nuclear Medicine, University Hospital Magdeburg, Leipziger Strass 44, Magdedurg, 39120, Germany

Source: International Journal of Molecular Sciences Published:2021


Abstract

The implication of ‘theranostic’ refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Related Docs
View other Related Docs
1. An Impressive Approach in Nuclear Medicine: Theranostics, PET Clinics (2021)
2. 68Ga-Fapi, a Twin Tracer for 18F-Fdg in the Era of Evolving Pet Imaging, Radiology-Nuclear Medicine Diagnostic Imaging: A Correlative Approach (2023)
3. Recent Clinical Implications of Fapi Imaging and Therapy, Clinical Nuclear Medicine (2024)
4. The Prognostic and Therapeutic Value and Clinical Implications of Fibroblast Activation Protein-Α As a Novel Biomarker in Colorectal Cancer, Cell Communication and Signaling (2023)
5. Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens, Diagnostics (2024)
6. Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted Pet Imaging in Oncology: A Systematic Review, Seminars in Nuclear Medicine (2025)
7. Exploring Innovative Strides in Radiolabeled Nanoparticle Progress for Multimodality Cancer Imaging and Theranostic Applications, Cancer Imaging (2024)
8. Historical Review of Pharmacological Development and Dosimetry of Psma-Based Theranostics for Prostate Cancer, Journal of Radioanalytical and Nuclear Chemistry (2019)
Experts (# of related papers)
View all Related Experts
Nasim Vahidfar (4)
Davood Beiki (4)
Other Related Docs
9. Immunopet: Antibody-Based Pet Imaging in Solid Tumors, Frontiers in Medicine (2022)
10. Radiolabeled Her2-Targeted Molecular Probes in Breast Cancer Imaging: Current Knowledge and Future Prospective, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
11. Evaluation of a New 99Mtc-Bombesin Analog in Differentiation of Malignant From Benign Breast Tumors, Iranian Journal of Nuclear Medicine (2015)
12. Bone Metastasis in Prostate Cancer: Bone Scan Versus Pet Imaging, Seminars in Nuclear Medicine (2024)
13. Comparative Analysis of Protein-Protein Interaction Networks in Metastatic Breast Cancer, PLoS ONE (2022)
14. Mucin-1 Conjugated Polyamidoamine-Based Nanoparticles for Image-Guided Delivery of Gefitinib to Breast Cancer, International Journal of Biological Macromolecules (2021)
15. Recent Progress in Immunotherapy of Breast Cancer Targeting the Human Epidermal Growth Factor Receptor 2 (Her2), Journal of Oncology Pharmacy Practice (2021)
16. Melatonin Aids in Treating Mood and Sleep Problems Resulting From Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial, Iranian Journal of Pharmaceutical Research (2024)
17. Dose-Dense Docetaxel Versus Weekly Paclitaxel Following Dose-Dense Epirubicin and Cyclophosphamide As Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis, International Journal of Breast Cancer (2021)
18. Fapi Pet/Ct Provides Higher Uptake and Better Target to Back Ground in Recurrent and Metastatic Tumors of Patients With Iodine Refractory Papillary Thyroid Cancer Compared With Fdg Pet Ct, Nuklearmedizin - NuclearMedicine (2023)
19. Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment, Molecular Imaging and Biology (2023)
20. Targeted Radioligand Therapy: Physics and Biology, Internal Dosimetry and Other Practical Aspects During 177Lu/225Ac Treatment in Neuroendocrine Tumors and Metastatic Prostate Cancer, Theranostics (2025)
21. Development and Evaluation of [64Cu]Cu-Dotatate for Clinical Applications, Iranian Journal of Nuclear Medicine (2023)
22. Tips and Tricks in Molecular Imaging: A Practical Approach, Frontiers in Biomedical Technologies (2021)
23. Tumor Immunology, Clinical Immunology (2022)
24. Cancer Imaging With Radiolabeled Monoclonal Antibodies, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
25. Car T Cell Therapy in Solid Tumors; With an Extensive Focus on Obstacles and Strategies to Overcome the Challenges, International Immunopharmacology (2021)
26. A Review of Various Modalities in Breast Imaging: Technical Aspects and Clinical Outcomes, Egyptian Journal of Radiology and Nuclear Medicine (2020)